DCOY · Forms 3, 4, 5
Insider trades at Decoy Therapeutics Inc.
No open-market insider buys or sells at Decoy Therapeutics Inc. in the last 90 days; 11 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Decoy Therapeutics Inc. (DCOY) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jonathan I Lieber | Director | Award | 2,000 | Form 4 | |||
| Frederick Pierce II | Chief Executive Officer | Award | 33,455 | Form 4 | |||
| Peter Klaus Marschel | Chief Business Officer | Award | 3,900 | Form 4 | |||
| Mark J Rosenblum | Chief Financial Officer | Award | 9,682 | Form 4 | |||
| Barbara Louise Hibner | Chief Scientific Officer | Award | 4,216 | Form 4 | |||
| Arnold C Hanish | Director | Award | 3,000 | Form 4 | |||
| Paul Lammers | Director | Award | 2,000 | Form 4 | |||
| Tess Burleson | Director | Award | 2,000 | Form 4 | |||
| William K. McVicar | Director | Award | 3,000 | Form 4 | |||
| Patricia G. Gauthier | Director | Award | 2,000 | Form 4 | |||
| Patricia G. Gauthier | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.